China to take four measures to reduce the price of high prices

BEIJING, May 25 (Xinhua) National Development and Reform Commission officials said 25th that the national Development and Reform Commission will take four measures to strengthen drug price management, increase the vicious increase in circulation, profiteering behavior, and further reduce the price of virtual high drugs.　　These four measures include: strengthen the market purchase and sale price investigation for the drugs which belong to the enterprise's own pricing, strengthen the cost audit to the government guided drugs, establish the dynamic adjustment mechanism of the basic drugs, and study the methods of improving the drug price management.　　According to the official, the price department will strengthen the market purchase and Sale price investigation, study and formulate the definition standard of profiteering, increase the attack on the vicious increase of the circulation link and profiteering, and then expose it. The price department will also strengthen the cost audit of government-guided drugs.　　For the inclusion of medical reimbursement, from the Independent pricing of enterprises to the government guidance, the official will verify the real price of the factory, strictly audit the cost of the details, to prevent the enterprise virtual listed costs, false prices. According to reports, at present, the National Development and Reform Commission is conducting a comprehensive investigation to reduce the high drug prices, to promote this year to achieve 60% of primary health care institutions to implement the basic drug system.　　The prices of other government-guided drugs will be reviewed in batches and adjusted according to the cost and changes in market supply and demand.　　In addition, the National Development and Reform Commission is revising the method of drug price management, exploring ways to promote the reduction of market transaction prices such as tendering and purchase. The official said that in the abolition of hospital drugs in the transition period, the National Development and Reform Commission in order to mobilize the hospital to use low-cost drugs, the initiative is not to break through the existing 15% fare increase policy, appropriate to reduce the rate of higher prices, the corresponding increase in the price of low-cost drugs, the implementation of differential fare The government will further expand the scope of the implementation of the standard of difference in drug dosage form, and prevent enterprises from adopting raise prices openly such as changing dosage forms and specifications.